Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
18%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
PPH
27
HOLDINGS
54%
ALSO IN XPH
XPH
47
HOLDINGS
28%
ALSO IN PPH
SECTOR DRIFT (PPH minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 23.8% | 3.0% | 3.0% |
|
MERCK & CO. INC. | 8.0% | 2.7% | 2.7% |
|
JOHNSON & JOHNSON | 4.6% | 2.6% | 2.6% |
|
BRISTOL-MYERS SQUIBB CO | 4.4% | 2.5% | 2.5% |
|
PFIZER INC | 4.7% | 2.4% | 2.4% |
PPH Overweight Relative to XPH
|
ELI LILLY & CO | 20.8% |
 |
NOVARTIS AG-ADR | 9.1% |
 |
NOVO-NORDISK A/S-SPONS ADR | 6.0% |
|
MERCK & CO. INC. | 5.3% |
 |
GLAXOSMITHKLINE PLC-SPON ADR | 4.8% |
|
MCKESSON CORP | 4.6% |
|
ASTRAZENECA PLC-SPONS ADR | 4.5% |
|
ABBVIE INC | 4.3% |
 |
SANOFI-AVENTIS-ADR | 4.2% |
|
CENCORA INC | 3.6% |
PPH Underweight Relative to XPH
|
NUVATION BIO INC CLASS A | -3.6% |
|
TARSUS PHARMACEUTICALS, INC. | -3.4% |
|
CRINETICS PHARMACEUTICALS INC | -3.0% |
|
LIQUIDIA TECHNOLOGIES, INC. | -2.9% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | -2.7% |
|
TERNS PHARMACEUTICALS, INC. | -2.6% |
|
LIGAND PHARMACEUTICALS-CL B | -2.5% |
|
ROYALTY PHARMA PLC CLASS A | -2.5% |
 |
JAZZ PHARMACEUTICALS PLC | -2.4% |
|
AXSOME THERAPEUTICS, INC. | -2.4% |